| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Single-Dose Crossover Pharmacokinetic Comparison Study of Oral, Rectal and Topical Quetiapine in Healthy Adults
|
Leung, Jonathan G.
|
|
2016
|
55 |
8 |
p. 971-976
|
article
|
| 2 |
Challenges in Individualizing Drug Dosage for Intensive Care Unit Patients: Is Augmented Renal Clearance What We Really Want to Know? Some Suggested Management Approaches and Clinical Software Tools
|
Jelliffe, Roger
|
|
2016
|
55 |
8 |
p. 897-905
|
article
|
| 3 |
Development of a Physiologically Based Pharmacokinetic/Pharmacodynamic Model to Predict the Impact of Genetic Polymorphisms on the Pharmacokinetics and Pharmacodynamics Represented by Receptor/Transporter Occupancy of Central Nervous System Drugs
|
Alqahtani, Saeed
|
|
2016
|
55 |
8 |
p. 957-969
|
article
|
| 4 |
Drug–Drug Interactions Between the Anti-Hepatitis C Virus 3D Regimen of Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and Eight Commonly Used Medications in Healthy Volunteers
|
Polepally, Akshanth R.
|
|
2016
|
55 |
8 |
p. 1003-1014
|
article
|
| 5 |
Drug Interactions with Lithium: An Update
|
Finley, Patrick R.
|
|
2016
|
55 |
8 |
p. 925-941
|
article
|
| 6 |
Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials
|
Madelain, Vincent
|
|
2016
|
55 |
8 |
p. 907-923
|
article
|
| 7 |
Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials
|
Madelain, Vincent
|
|
|
55 |
8 |
p. 907-923
|
article
|
| 8 |
Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients with Atrial Tachyarrhythmias
|
Salem, Joe-Elie
|
|
2016
|
55 |
8 |
p. 991-1002
|
article
|
| 9 |
Population Pharmacokinetics of Daclizumab High-Yield Process in Healthy Volunteers and Subjects with Multiple Sclerosis: Analysis of Phase I–III Clinical Trials
|
Diao, Lei
|
|
2016
|
55 |
8 |
p. 943-955
|
article
|
| 10 |
Quantitative Prediction of Drug Interactions Caused by CYP1A2 Inhibitors and Inducers
|
Gabriel, Laurence
|
|
2016
|
55 |
8 |
p. 977-990
|
article
|
| 11 |
Revisiting Dosing Regimen Using Pharmacokinetic/Pharmacodynamic Mathematical Modeling: Densification and Intensification of Combination Cancer Therapy
|
Meille, Christophe
|
|
2016
|
55 |
8 |
p. 1015-1025
|
article
|
Journal description